1. Home
  2. AREN vs KAPA Comparison

AREN vs KAPA Comparison

Compare AREN & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • KAPA
  • Stock Information
  • Founded
  • AREN 2016
  • KAPA 2013
  • Country
  • AREN United States
  • KAPA United States
  • Employees
  • AREN N/A
  • KAPA N/A
  • Industry
  • AREN Medical/Dental Instruments
  • KAPA
  • Sector
  • AREN Health Care
  • KAPA
  • Exchange
  • AREN Nasdaq
  • KAPA NYSE
  • Market Cap
  • AREN 20.7M
  • KAPA 21.3M
  • IPO Year
  • AREN N/A
  • KAPA 2024
  • Fundamental
  • Price
  • AREN $1.75
  • KAPA $1.56
  • Analyst Decision
  • AREN
  • KAPA Strong Buy
  • Analyst Count
  • AREN 0
  • KAPA 1
  • Target Price
  • AREN N/A
  • KAPA $9.00
  • AVG Volume (30 Days)
  • AREN 5.0M
  • KAPA 698.3K
  • Earning Date
  • AREN 11-14-2024
  • KAPA 11-23-2024
  • Dividend Yield
  • AREN N/A
  • KAPA N/A
  • EPS Growth
  • AREN N/A
  • KAPA N/A
  • EPS
  • AREN N/A
  • KAPA N/A
  • Revenue
  • AREN $207,974,000.00
  • KAPA N/A
  • Revenue This Year
  • AREN $12.73
  • KAPA N/A
  • Revenue Next Year
  • AREN $71.95
  • KAPA N/A
  • P/E Ratio
  • AREN N/A
  • KAPA N/A
  • Revenue Growth
  • AREN 10.88
  • KAPA N/A
  • 52 Week Low
  • AREN $0.56
  • KAPA $1.22
  • 52 Week High
  • AREN $4.74
  • KAPA $4.00
  • Technical
  • Relative Strength Index (RSI)
  • AREN 86.29
  • KAPA N/A
  • Support Level
  • AREN $0.56
  • KAPA N/A
  • Resistance Level
  • AREN $0.65
  • KAPA N/A
  • Average True Range (ATR)
  • AREN 0.11
  • KAPA 0.00
  • MACD
  • AREN 0.07
  • KAPA 0.00
  • Stochastic Oscillator
  • AREN 73.25
  • KAPA 0.00

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about the things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About KAPA KAIROS PHARMA LTD

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.

Share on Social Networks: